Quality-of-life issues in survivors to anaphylactic reactions to drugs

I. Baiardini, F. Gaeta, G. Molinengo, F. Braido, G. W. Canonica, A. Romano

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The aim of this cross-sectional observational study was to explore quality of life and well-being in patients with drug-induced anaphylaxis. Two validated tools were used: the Drug Hypersensitivity Quality-of-Life Questionnaire (DrHy-Q) and the Psychological General Well-Being Index (PGWBI). Sixty-five patients (13 males) underwent data analysis. The mean DrHy-Q score was 62.82 ± 12.1. Mean PGWBI score was 64.03 ± 17.66. DrHy-Q score was significantly correlated with PGWBI total score (r = -0.314; P = 0.011) and with the following domains: Anxiety (r = -0.260; P = 0.036), Depressed mood (r = -0.406; P = 0.001), Positive well-being (r = -0.251; P = 0.004), and General Health (r = -0.352; P = 0.004). Compared with the Italian reference population, patients had a significantly reduced PGWBI total and domain score. Our results highlight for the first time how impaired HRQoL and distress commonly feature in survivors to anaphylactic reactions to drug.

Original languageEnglish
Pages (from-to)877-879
Number of pages3
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume70
Issue number7
DOIs
Publication statusPublished - Jul 1 2015

Fingerprint

Anaphylaxis
Drug Hypersensitivity
Survivors
Quality of Life
Psychology
Pharmaceutical Preparations
Observational Studies
Anxiety
Cross-Sectional Studies
Health
Population
Surveys and Questionnaires

Keywords

  • anaphylaxis
  • drugs
  • quality of life
  • well-being

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Quality-of-life issues in survivors to anaphylactic reactions to drugs. / Baiardini, I.; Gaeta, F.; Molinengo, G.; Braido, F.; Canonica, G. W.; Romano, A.

In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 70, No. 7, 01.07.2015, p. 877-879.

Research output: Contribution to journalArticle

Baiardini, I. ; Gaeta, F. ; Molinengo, G. ; Braido, F. ; Canonica, G. W. ; Romano, A. / Quality-of-life issues in survivors to anaphylactic reactions to drugs. In: Allergy: European Journal of Allergy and Clinical Immunology. 2015 ; Vol. 70, No. 7. pp. 877-879.
@article{5141ed10b3684a9cb2de93db5c468caa,
title = "Quality-of-life issues in survivors to anaphylactic reactions to drugs",
abstract = "The aim of this cross-sectional observational study was to explore quality of life and well-being in patients with drug-induced anaphylaxis. Two validated tools were used: the Drug Hypersensitivity Quality-of-Life Questionnaire (DrHy-Q) and the Psychological General Well-Being Index (PGWBI). Sixty-five patients (13 males) underwent data analysis. The mean DrHy-Q score was 62.82 ± 12.1. Mean PGWBI score was 64.03 ± 17.66. DrHy-Q score was significantly correlated with PGWBI total score (r = -0.314; P = 0.011) and with the following domains: Anxiety (r = -0.260; P = 0.036), Depressed mood (r = -0.406; P = 0.001), Positive well-being (r = -0.251; P = 0.004), and General Health (r = -0.352; P = 0.004). Compared with the Italian reference population, patients had a significantly reduced PGWBI total and domain score. Our results highlight for the first time how impaired HRQoL and distress commonly feature in survivors to anaphylactic reactions to drug.",
keywords = "anaphylaxis, drugs, quality of life, well-being",
author = "I. Baiardini and F. Gaeta and G. Molinengo and F. Braido and Canonica, {G. W.} and A. Romano",
year = "2015",
month = "7",
day = "1",
doi = "10.1111/all.12610",
language = "English",
volume = "70",
pages = "877--879",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0105-4538",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Quality-of-life issues in survivors to anaphylactic reactions to drugs

AU - Baiardini, I.

AU - Gaeta, F.

AU - Molinengo, G.

AU - Braido, F.

AU - Canonica, G. W.

AU - Romano, A.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - The aim of this cross-sectional observational study was to explore quality of life and well-being in patients with drug-induced anaphylaxis. Two validated tools were used: the Drug Hypersensitivity Quality-of-Life Questionnaire (DrHy-Q) and the Psychological General Well-Being Index (PGWBI). Sixty-five patients (13 males) underwent data analysis. The mean DrHy-Q score was 62.82 ± 12.1. Mean PGWBI score was 64.03 ± 17.66. DrHy-Q score was significantly correlated with PGWBI total score (r = -0.314; P = 0.011) and with the following domains: Anxiety (r = -0.260; P = 0.036), Depressed mood (r = -0.406; P = 0.001), Positive well-being (r = -0.251; P = 0.004), and General Health (r = -0.352; P = 0.004). Compared with the Italian reference population, patients had a significantly reduced PGWBI total and domain score. Our results highlight for the first time how impaired HRQoL and distress commonly feature in survivors to anaphylactic reactions to drug.

AB - The aim of this cross-sectional observational study was to explore quality of life and well-being in patients with drug-induced anaphylaxis. Two validated tools were used: the Drug Hypersensitivity Quality-of-Life Questionnaire (DrHy-Q) and the Psychological General Well-Being Index (PGWBI). Sixty-five patients (13 males) underwent data analysis. The mean DrHy-Q score was 62.82 ± 12.1. Mean PGWBI score was 64.03 ± 17.66. DrHy-Q score was significantly correlated with PGWBI total score (r = -0.314; P = 0.011) and with the following domains: Anxiety (r = -0.260; P = 0.036), Depressed mood (r = -0.406; P = 0.001), Positive well-being (r = -0.251; P = 0.004), and General Health (r = -0.352; P = 0.004). Compared with the Italian reference population, patients had a significantly reduced PGWBI total and domain score. Our results highlight for the first time how impaired HRQoL and distress commonly feature in survivors to anaphylactic reactions to drug.

KW - anaphylaxis

KW - drugs

KW - quality of life

KW - well-being

UR - http://www.scopus.com/inward/record.url?scp=84931561271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931561271&partnerID=8YFLogxK

U2 - 10.1111/all.12610

DO - 10.1111/all.12610

M3 - Article

C2 - 25789409

AN - SCOPUS:84931561271

VL - 70

SP - 877

EP - 879

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

SN - 0105-4538

IS - 7

ER -